Publications by authors named "B Camps"

Claim this Profile
F
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, Ruth de Francisco, Francisco Javier García-Alonso, Blau Camps

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence.
Míriam Mañosa, Blanca Oller, Esther Garcia-Planella, Jordi Guardiola, Fiorella Cañete, Blau Camps

Dig Liver Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry.
Margalida Calafat, Carles Suria, Francisco Mesonero, Ruth de Francisco, Carmen Yagüe Caballero, Blau Camps

Am J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.
Carlos González-Muñoza, Margalida Calafat, Javier P Gisbert, Eva Iglesias, Miguel Mínguez, Blau Camps

Postgrad Med J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of a microbial signature as a predictor of endoscopic post-surgical recurrence in patients with Crohn's disease.
Lia Oliver, Blau Camps, David Julià-Bergkvist, Joan Amoedo, Sara Ramió-Pujol

Front Mol Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis